Inhibitors of apoptosis: expression and regulation in the endometrium during the estrous cycle and at the maternal-conceptus interface during pregnancy in pigs

Objective Caspase-mediated apoptosis plays a crucial role in the regulation of endometrial and placental function in females. Caspase activity is tightly controlled by members of the inhibitors of apoptosis proteins (IAPs) family. However, the expression and regulation of IAPs at the maternal-conceptus interface has not been studied in pigs. Therefore, we determined the expression of IAP family members baculovirus IAP repeat-containing 1 (BIRC1) to BIRC6 at the maternal-conceptus interface in pigs. Methods We obtained endometrial tissues from pigs at various stages of the estrous cycle and pregnancy, conceptus tissues during early pregnancy, and chorioallantoic tissues during mid- to late pregnancy and analyzed the expression of IAPs. Furthermore, we determined the effects of the steroid hormones estradiol-17β (E2) and progesterone on the expression of IAPs in endometrial explant tissue cultures. Results During the estrous cycle, BIRC2 and BIRC5 expression varied cyclically, and during pregnancy, endometrial BIRC1, BIRC2, BIRC3, BIRC4, and BIRC5 expression varied in a stage-specific manner. Conceptus and chorioallantoic tissues also expressed IAPs during pregnancy. The BIRC2 and BIR3 mRNAs were localized to luminal epithelial cells, and BIRC4 proteins to glandular epithelial cells in the endometrium. Exposure of endometrial tissues to E2 increased the expression of BIRC6, while progesterone increased the expression of BIRC1, BIRC4, and BIRC6 in a dose-dependent manner. Conclusion These results indicated that IAPs were expressed in the endometrium during the estrous cycle and at the maternal-conceptus interface during pregnancy in a stage-specific manner. In addition, steroid hormones were found to be responsible for the expression of some IAPs in pigs. Together, the results suggested that IAPs may play important roles in endometrial and placental functions by regulating caspase action and apoptosis at the maternal-conceptus interface.


INTRODUCTION
Apoptosis, a process of programmed cell death, is an important cellular event in many biological processes, including tissue homeostasis, development, and immunity [1]. Apoptosis also plays a critical role in reproductive processes such as functional maintenance of the endometrium and embryo implantation [2]. In humans, apoptosis allows the elimination of senescent cells from the functional layer of the endometrium during the menstrual cycle [2]. During early pregnancy, interactions between the embryo and endometrium facilitate adhesion and invasion of the implanting embryo, which leads to complete apoptosis of the epithelial layer at the implantation site [3]. In non-primate species, menstruation does not occur as part of the estrous cycle, but apoptosis is nonetheless involved in endo-metrial remodeling during cyclical cell proliferation and degeneration. In mice, apoptosis in the uterine tissue is regulated by ovarian steroid hormones during the estrous cycle and occurs in the decidua after implantation [4][5][6] In pigs, apoptotic cells have been detected in the endometrium during the estrous cycle and pregnancy, mostly in the stroma at the time of implantation [7,8]. Our previous study in pigs showed that many maternal T cells are recruited into the endometrium during the implantation period [9], and some T cells expressing cell death receptors undergo apoptosis [8].
Apoptotic cell death is mediated by a family of cysteineaspartic proteases called caspases (CASPs) that are widely expressed in most cells [1]. The CASPs associated with apoptosis are classified as initiator (CASP2, CASP8, CASP9, and CASP10) or executioner (CASP3, CASP6, and CASP7) CASPs according to their activity [10]. Initiator CASPs activate other executioner CASPs [11,12]. Executioner CASPs, especially CASP3 and CASP7, cleave various substrates that are essential for cell survival. The cleavage of cell survival factors results in degradation of cytoskeletal proteins and DNA fragmentation, leading to cell death without spillage of its contents [1,11,13]. Our recent study in pigs indicated that the expression of CASP3 and CASP7 increases in the endometrium at the time of implantation, and an active form of CASP3 is localized to endometrial epithelial and stromal cells [14]. Interestingly, during early pregnancy, we detected only a few apoptotic cells in the endometrial stroma and none in the epithelium [14], suggesting a mechanism to regulate apoptosis in a cell-type specific manner may be present in the endometrium during the implantation period in pigs.
A few studies have reported the expression and function of some IAPs in the endometrium and placentas in humans and rodents. In humans, BIRC3 and BIRC5 are expressed in the endometrium, and aberrant expression of these IAPs is associated to endometriosis and endometrial cancer [23][24][25]. In human placentas, IAPs are expressed primarily in cytotrophoblast cells and the syncytiotrophoblast layer during pregnancy, and BIRC3 expression prevents apoptosis in cytotrophoblast cells [26,27]. In addition, survival and proliferation of trophoblast cells are also related to the expression of BIRC4 and BIRC5, respectively, during pregnancy in humans and rodents [28][29][30]. Although the expression and function of IAPs in the endometrium and placenta have been investigated in humans and rodents, little is known about the expression, regulation, and function of IAPs in the endometrium during the estrous cycle and pregnancy in pigs.
Because CASP3 and CASP7 are expressed in the endometrial epithelium at the time of conceptus implantation without causing apoptotic cell death, and IAPs are responsible for inhibiting caspases, we postulated that IAPs may regulate endometrial epithelial cell differentiation and homeostasis during both the estrous cycle and pregnancy in pigs. Therefore, to initiate our study of the regulatory mechanism of apoptosis in the endometrium at the maternal-conceptus interface in pigs, we assessed i) the expression of IAPs for which porcine sequence information is available (BIRC1, BIRC2, BIRC3, BIRC4, BIRC5, and BIRC6) in the endometrium during the estrous cycle and pregnancy, in conceptus tissues during early pregnancy, and in chorioallantoic tissues during mid-to late pregnancy; ii) the localization of IAPs in the endometrium; and iii) the regulation of endometrial tissue IAP expression by the steroid hormones estrogen and progesterone.

Animals and tissue preparation
All experimental procedures involving animals were conducted in accordance with the Guide for the Care and Use of Research Animals in Teaching and Research and approved by the Institutional Animal Care and Use Committee of Yonsei University (No. YWC-P120) and the National Institute of Animal Science (No. 2015-137). Sexually mature Landrace-Yorkshire gilts of similar age (6 to 8 months) and weight (100 to 120 kg) were assigned randomly to either the cycling or pregnant groups, as described previously [31]. Gilts assigned to the pregnant group were artificially inseminated with fresh boar semen at the onset of estrus (day 0) and 12 h later. The reproductive tracts of the gilts were obtained immediately after slaughter on days 0, 3, 6, 9, 12, 15, or 18 of the estrous cycle or days 10, 12, 15, 30, 60, 90, or 114 of pregnancy (n = 3-6/d/status). Pregnancy was confirmed by the presence of apparently normal filamentous conceptuses in uterine flushings on days 10, 12, and 15 and the presence of embryos and placenta on later days of pregnancy. Conceptus tissues were obtained by uterine flushing on days 12 and 15 of pregnancy. Uterine flushing was performed by introducing and recovering 25 mL of phosphate-buffered saline (PBS; pH 7.4) into each uterine horn. Chorioallantoic tissues were obtained on days 30, 60, 90, and 114 of pregnancy (n = 3-4/d). Endometrial tissues from prepubertal gilts (n = 8; approximately 6 months of age) that had not undergone an estrous cycle and with no corpus luteum formed were obtained from a local slaughterhouse. Endometrium, dissected free of myometrium, was collected from the middle portion of each uterine horn, snap-frozen in liquid nitrogen, and stored at -80°C prior to RNA extraction. For immunohistochemistry, cross-sections of the endometrium were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 24 h and then embedded in paraffin as previously described [32].

Explant cultures
To determine the effects of the steroid hormones estradiol-17β (E2) and progesterone (P4) on the expression of six IAP mRNAs in the endometrium, endometrial explant tissues obtained from prepubertal gilts were cultured as previously described [14,31]. The endometrium was dissected free of the myometrium and placed into warm phenol-red-free Dulbecco's modified Eagle's medium/F-12 culture medium (DMEM/F-12; Sigma, St. Louis, MO, USA) containing penicillin G (100 IU/mL) and streptomycin (0.1 mg/mL). The endometrium was minced into small pieces (2 to 3 mm 3 ) using scalpel blades, and 500 mg aliquots were placed into T25 flasks with serum-free modified DMEM/F-12 containing 10 μg/mL insulin (Sigma, USA), 10 ng/mL transferrin (Sigma, USA), and 10 ng/mL hydrocortisone (Sigma, USA). Endometrial explants were cultured immediately after mincing in the presence of increasing concentrations of E2 (0, 5, 50, or 500 pg/mL; Sigma, USA) or P4 (0, 0.3, 3, or 30 ng/mL; Sigma, USA) for 24 h with rocking in an atmosphere of 5% CO 2 in air at 37°C. The selected concentrations encompassed the full range of physiological concentrations of E2 and P4 [33]. Explant tissues were then harvested, and total RNA was extracted for real-time reverse transcription-polymerase chain reaction (RT-PCR) to determine the expression of BIRC1, BIRC2, BIRC3, BIRC4, BIRC5, and BIRC6 mRNAs.

IAP cDNAs
Total RNA was extracted from endometrial, conceptus, and chorioallantoic tissues using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's recommendations. The quantity of RNA was assessed spectrophotometrically, and RNA integrity was validated following electrophoresis in 1% agarose gel. Four micrograms of total RNA were treated with DNase I (Promega, Madison, WI, USA) and reverse transcribed using SuperScript II Reverse Transcriptase (Invitrogen, USA) to obtain complementary DNAs (cDNAs). The cDNA templates were then diluted 1:4 with nuclease-free water and amplified by PCR using Taq polymerase (Takara Bio, Shiga, Japan) and specific primers based on porcine IAP mRNA sequences. The PCR conditions, sequences of primer pairs for IAPs and expected product sizes are listed in Table 1. The PCR products were separated on 2% agarose gels and visualized using ethidium bromide staining. The identity of each amplified PCR product was verified by sequence analysis after cloning into the TOPOII vector (Invitrogen, USA).

Quantitative real-time reverse transcriptionpolymerase chain reaction
To analyze the expression of six IAP mRNAs in endometrial and chorioallantoic tissues, real-time RT-PCR was performed using the Applied Biosystems StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) and the SYBR Green method. Complementary DNAs were synthesized from 4 μg total RNA isolated from each endometrial tissue, and newly synthesized cDNAs (total volume of 21 μL) were diluted 1:4 with nuclease-free water and then used for PCR. The Power SYBR Green PCR Master Mix (Applied Biosystems, USA) was used for PCR reactions. The final reaction volume of 20 μL included 2 μL of cDNA, 10 μL of 2X Master mix, 2 μL of each primer (100 nM), and 4 μL of dH 2 O. The PCR conditions and sequences of primer pairs are listed in Table 1. The results were reported as expression relative to that detected on day 0 of the estrous cycle, that on day 30 of pregnancy in chorioallantoic tissues, or that in control explant tissues after normalization of the amount of transcript to the geometric mean of endogenous porcine ribosomal protein L7 (RPL7) and ubiquitin B (UBB), and TATA binding protein (TBP) controls, all using the 2 -ΔΔCT method as previously described [34].

In situ hybridization
The nonradioactive in situ hybridization procedure was performed as described previously [35], with some modifications. Sections (5 μm thick) were rehydrated by soaking them in successive xylene, 100% ethanol, 95% ethanol, and diethylpyrocarbonate (DEPC)-treated water baths. Tissue sections were boiled in citrate buffer (pH 6.0) for 10 min. After wash-ing in DEPC-treated PBS, sections were digested using 5 μg/ mL proteinase K (Sigma, USA) in 100 mM Tris-HCl and 50 mM ethylenediaminetetraacetic acid, pH 7.5, at 37°C. After post-fixation in 4% paraformaldehyde, tissue sections were incubated twice in PBS containing 0.1% active DEPC for 15 min and equilibrated for 15 min in 5× saline sodium citrate (SSC). The sections were prehybridized for 2 h at 68°C in hybridization mix (50% formamide, 5× SSC, 500 μg/mL herring sperm DNA, and 250 μg/mL yeast tRNA). Sense and antisense BIRC2 and BIRC3 riboprobes labeled with digoxigenin (DIG)-UTP were denatured for 5 min at 80°C and added to the hybridization mix. The hybridization reaction was carried out overnight at 68°C. Prehybridization and hybridization reactions were performed in a box saturated with a 5× SSC and 50% formamide solution to avoid evaporation, and no coverslips were used. After hybridization, sections were washed for 30 min in 2× SSC at room temperature, 1 h in 2× SSC at 65°C, and 1 h in 0.1× SSC at 65°C. Probes bound to the sections were detected immunologically using sheep anti-DIG Fab fragments covalently coupled to alkaline phosphatase and nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate (toluidine salt) as chromogenic substrate, according to the manufacturer's protocol (Roche, Indianapolis, IN, USA).

Immunohistochemistry
To identify the type(s) of porcine endometrial cells expressing BIRC4, sections were immunostained. Sections (5 μm thick) from paraffin-embedded tissues were deparaffinized and rehydrated in an alcohol gradient. Tissue sections were boiled in citrate buffer, pH 6.0, for 10 min, then washed with PBS and blocked with 0.5% (v/v) H 2 O 2 in methanol for 30 min. Tissue sections were then blocked with 10% normal goat serum for 30 min at room temperature. Rabbit polyclonal anti-BIRC4 antibody (3 μg/mL; OriGene Technologies, Rockville, MD, USA) was added, and sections were incubated overnight at 4°C in a humidified chamber. For each tissue tested, purified normal rabbit immunoglobulin G was substituted for the primary antibody as a negative control. Tissue sections were washed three times with PBST. Biotinylated goat anti-rabbit secondary antibody (1 μg/mL; Vector Laboratories, Burlingame, CA, USA) was added, and sections were incubated for 1 h at room temperature. Following washes with PBST, a streptavidin-peroxidase conjugate (Invitrogen, USA) was added to the tissue sections, which were then incubated for 10 min at room temperature. The sections were washed with PBST, and a Peroxidase Substrate Kit (Vector Laboratories, USA) mixture was added to the tissue sections, which were then incubated for 10 min at room temperature. The tissue sections were washed in water, counterstained with Mayer's hematoxylin, and coverslipped.

Statistical analyses
Real-time RT-PCR data for six IAPs were subjected to an analysis of variance using the general linear models of SAS (Cary, NC, USA). As sources of variation, models included day, pregnancy status (cyclic or pregnant, days 12 and 15 post-estrus), and interactions to evaluate steady-state expression of the selected IAP mRNAs. Real-time RT-PCR data were analyzed by least squares regression analyses to assess the effects of day of the estrous cycle (day 0, 3, 6, 9, 12, 15, and 18) and pregnancy (day 10, 12, 15, 30, 60, 90, and 114) in the endometrium, and the effects of day of pregnancy in chorioallantoic tissue (day 30, 60, 90, and 114), and the effect of E2 and P4 on IAP expression in endometrial explant tissues. Data are presented as means with the standard errors of the mean. A p-value less than 0.05 was considered significant, whereas p-values if 0.05 to 0.10 were considered indicative of a trend toward significance.

RESULTS
Expression of BIRC1, BIRC2, BIRC3, BIRC4, BIRC5, and BIRC6 mRNAs in the endometrium during the estrous cycle and pregnancy in pigs To determine whether mRNAs for the BIRC1, BIRC2, BIRC3, BIRC4, BIRC5, and BIRC6 IAPs were expressed in the endometrium of pigs, we performed real-time RT-PCR analyses (Figure 1). During the estrous cycle, the expression of BIRC2 and BIRC5, but not other IAPs, varied cyclically, with increased expression of BIRC2 at proestrus (linear effect of day, p<0.01) and BIRC5 at metestrus (linear effect of day, p<0.05). On days 12 and 15 post-estrus, BIRC5 expression was affected by pregnancy status (p<0.05), but not by day or day×pregnancy status, and the expression of BIRC5 was greater in the endometrium on day 12 of pregnancy than during the estrous cycle (p<0.05). The expression of BIRC4 and BIRC6 was affected by day (p<0.05), but not by pregnancy status or day×pregnancy status, with greater expression on day 12 than day 15. The steady-state expression of BIRC1, BIRC2, BIRC3, BIRC4, and BIRC5, but not BIRC6, was altered during pregnancy, with increased expression of BIRC1, BIRC2, BIRC3, and BIRC4 during early pregnancy (linear effect of day, p<0.01 for BIRC1 and BIRC3; p<0.05 for BIRC2 and BIRC4) and increased expression of BIRC5 during mid-to late pregnancy (cubic effect of day, p<0.01).

Expression of BIRC1, BIRC2, BIRC3, BIRC4, BIRC5, and BIRC6 mRNAs in conceptuses during early pregnancy and chorioallantoic tissue during later stages of pregnancy
To determine whether BIRC1, BIRC2, BIRC3, BIRC4, BIRC5, and BIRC6 were expressed by conceptuses during early pregnancy (days 12 and 15), we performed RT-PCR using cDNA from conceptuses from days 12 and 15 of pregnancy. All IAP mRNAs were detected in conceptus tissues at both day 12   Figure 2B).

Localization of BIRC2 and BIRC3 mRNAs and BIRC4 protein in the endometrium on days 12 and 15 of pregnancy in pigs
Next, we performed in situ hybridization analyses to determine which cell type(s) express BIRC2 and BIRC3 mRNAs in the endometrium on days 12 and 15 of pregnancy. The expression of BIRC2 and BIRC3 mRNAs was localized primarily to endometrial epithelial cells with strong signal intensity in luminal epithelial (LE) cells. We also performed immunohistochemistry to identify BIRC4 protein in the endometrium and found that BIRC4 protein was localized to glandular epithelial (GE) cells in the endometrium with strong signal intensity on day 12 of pregnancy ( Figure 3C).

Effects of steroid hormones E2 and P4 on BIRC1, BIRC2, BIRC3, BIRC4, BIRC5, and BIRC6 expression in endometrial tissues
Because the expression of some BIRCs varied during the estrous cycle, we investigated whether steroid hormones, E2 and P4, affected the expression of IAPs, BIRC1, BIRC2, BIRC3, BIRC4, BIRC5, and BIRC6, in endometrial tissues. To assess the individual effects of E2 or P4, and to exclude the possibility that these hormones influenced endometrial tissues during the estrous cycle, we utilized endometrial tissues from prepubertal gilts that had not yet undergone an estrous cycle. When we cultured endometrial explant tissues with increasing concentrations of E2 or P4, P4 induced the expression of BIRC1, BIRC4, and BIRC6 mRNAs (linear effect of dose, p<0.01; Figure 4), while E2 did not affect the expression of IAP expression in endometrial tissues ( Figure 5).

DISCUSSION
The novel findings of this study of female pigs were i) the endometrium expressed IAPs during the estrous cycle and pregnancy in a stage-and pregnancy-status-specific manner; ii) conceptuses on days 12 and 15 of pregnancy expressed IAPs; iii) chorioallantoic tissues from day 30 to the end of gestation had progressively increasing (BIRC1, BIRC2, BIRC3, BIRC4, and BIRC6) or decreasing (BIRC5) expression of IAPs; iv) BIRC2 and BIRC3 mRNAs were localized predominantly within endometrial LE cells and BIRC4 protein within endometrial GE cells during early pregnancy; v) estrogen induced the expression of BIRC6, and progesterone induced the expression of BIRC1, BIRC4, and BIRC6 in a concentration-dependent manner in endometrial explant tissues.
The IAPs are important regulators of apoptosis and play crucial roles in a variety of biological processes, such as tissue homeostasis, development, and immunity [1]. Endometrial and placental IAP expression has been confirmed in both humans and rodents. In humans, BIRC4 is expressed in the endometrium and placenta during the reproductive cycle and pregnancy and is involved in regulation of endometrial remodeling and placental development [36]. Increased expression of BIRC2, BIRC3, BIRC4, and BIRC5 is associated with endometriosis, and tumor necrosis factor-α increases BIRC3 expression in endometrial stromal cells in vitro [24].
In addition, IAPs are expressed in cytotrophoblast cells and the syncytiotrophoblast layer during pregnancy [26]. However, the expression of IAP family members in the endometrium throughout the estrous cycle and at the maternal-conceptus interface during pregnancy has not been fully determined in any species. The present study demonstrated the dynamic  expression of IAPs in the endometrium throughout the estrous cycle and pregnancy and in conceptus and chorioallantoic tissues during pregnancy in pigs. The expression of BIRC2, BIRC3, and BIRC5 varied cyclically during the estrous cycle, with peak BIRC2 and BIRC3 expression occurring during the proestrus phase and of BIRC5 during the metestrus phase. Our previous study showed that caspases are expressed in the endometrium during the estrous cycle and pregnancy in pigs [14]. The expression pattern of BIRC2 and BIRC3 is similar to those of CASP6, CASP7, and CASP8, and the expression pattern of BIRC5 is similar to CASP10 during the estrous cycle [14]. Because BIRC2 and BIRC3 inhibit the action of CASP8 [37], and BIRC5 inhibits active forms of CASP3 and CASP7 [38], the results of this study suggest that differential expression of BIRC2, BIRC3, and BIRC5 during the different stages of the estrous cycle is responsible for tight regulation of CASP3, CASP7, and CASP8 actions in the endometrium during the estrous cycle in pigs.
Although the expression and activity of IAPs have been demonstrated at the maternal-fetal interface of both humans and rodents [28,29,36,39], most of these studies have focused on the expression of BIRC4 and BIRC5. In this study, we found that all IAPs studied were expressed in the endometrium and their expression (except for BIRC6) varied in a stage-specific manner during pregnancy. The expression of BIRC1, BIRC2, BIRC3, and BIRC4 was greater during early pregnancy than mid-to late pregnancy, suggesting that the expression of IAPs is pregnancy stage-specific and may play an important role in regulating endometrial functions for the establishment of pregnancy during the peri-implantation period. Expression of BIRC5 was greater during mid-pregnancy than early or late pregnancy, a pattern that corresponded with the onset and completion of placentation. Thus, it is likely that increased BIRC5 expression during mid-pregnancy may be involved in support of placental development. In addition, these results suggested that depending on the stage of pregnancy, different IAP members are responsible for inhibition of apoptosis in the endometrium.
We also determined the cell type(s) expressing IAPs mRNAs or proteins in the endometrium during the estrous cycle and early pregnancy. Our results showed that BIRC2 and BIRC3 mRNAs were localized to LE cells and BIRC4 proteins to GE cells during early pregnancy. Our previous study demonstrated that active CASP3 proteins are localized to LE and stromal cells and CASP7 is localized to LE cells during early pregnancy, but cells undergoing apoptosis in the endometrium were detected only in the stroma [14]. Notably, the endometrial expression of CASP3 and CASP7 is induced by conceptus signals, interleukin-1β and interferon-γ, respectively [14]. The executioner caspases CASP3, CASP6, and CASP7 play important roles not only in apoptotic cell death, but also in cell differentiation in various cell types, including muscle cells, neurons, stem cells, trophoblasts, and epithelial cells [40]. Indeed, endometrial epithelial cells undergo a dramatic differentiation process during the implantation period to establish cell-tocell interactions with trophectodermal cells to form a true epitheliochorial type of placenta in pigs [41]. The process of endometrial LE cell differentiation during the implantation period comprises altered epithelial morphology, increased secretory activity, and increased expression of immunityrelated molecules in response to conceptus signals, estrogen, interleukin-1β, or interferon-γ [14,33]. Thus, it is likely that CASP3 and CASP7 are involved in the differentiation process of endometrial LE cells, and IAPs expressed in LE cells regulate CASP3 and CASP7 activity to inhibit caspase-mediated apoptotic cell death and protect LE cells. However, the detailed mechanisms of action of caspases and IAPs in endometrial LE cells during the differentiation process still need to be clarified.
The expression of CASP6, CASP7, CASP8, CASP9, and CASP10 in chorioallantoic tissues increases from mid-pregnancy to the end of gestation, although apoptotic cells are barely detectable in chorioallantoic tissues during pregnancy in pigs [14]. Our study results showed that IAPs were expressed in conceptus tissues during early pregnancy and in chorioallantoic tissues during mid-to late pregnancy. In particular, the expression of BIRC1, BIRC2, BIRC3, BIRC4, and BIRC6 in chorioallantoic tissues increased progressively from conception to the end of gestation. Expression of IAPs in cytotrophoblast cells and the syncytiotrophoblast layer in the human placentas protects cytotrophoblast cells from undergoing apoptosis [26,27]. Thus, our results suggest that the increased expression of IAPs in chorioallantoic tissues during mid-to late pregnancy is responsible for regulation of caspase activity to protect chorioallantoic tissues from undergoing apoptosis. Interestingly, BIRC5 expression in chorioallantoic tissues decreased toward the end of the gestation period in this study. In abortion-prone mice, increased placental BIRC5 expression during early pregnancy is associated with pregnancy loss, although the role of BIRC5 in pregnancy failure is not fully understood [39]. Thus, tight regulation of BIRC5 expression in the placenta may be critical for the maintenance of successful pregnancy, but the specific mechanism of BIRC5 regulation of chorioallantoic tissues apoptosis and pregnancy outcomes needs further study.
In this study, endometrial expression of BIRC2, BIRC3, and BIRC5 varied during the porcine estrous cycle, while expression of BIRC1, BIRC2, BIRC3, BIRC4, and BIRC5 varied during pregnancy. Although transcriptional regulation of IAPs is not well understood, some studies have reported that the steroid hormones E2 and P4, together with the cytokines' tumor necrosis factor-α and transforming growth factor-β, regulate IAP expression in the endometrium in humans and rats [24,[42][43][44]. In humans, the expression of BIRC5 in endometrial tissues is induced by E2 and reduced by P4 [44]; in contrast, endometrial BIRC4 expression is induced by E2 in ovariectomized rats [42]. Thus, differential expression of IAPs in the endometrium led us to postulate that ovarian steroid hormones might be involved in regulation of endometrial IAP expression. Indeed, in this study, E2 increased the expression of BIRC6 in porcine endometrial explant tissue cultures, and P4 increased the expression of BIRC1, BIRC4, and BIRC6, suggesting that the expression of some IAPs in the endometrium during the estrous cycle and pregnancy are regulated by steroid hormones. Although we have not determined the effect of tumor necrosis factor-α and transforming growth factor-β on IAP expression, it is possible that these and other factors may also affect the expression of IAPs in endometrial and chorioallantoic tissues in pigs.
In conclusion, the results of this study in pigs indicated that IAPs were expressed in the endometrium during the estrous cycle and pregnancy, and in conceptus and chorioallantoic tissues during pregnancy; BIRC2 and BIRC3 mRNAs were localized to endometrial LE cells, and BIRC4 proteins were localized to GE cells; and the steroid hormones E2 and/or P4 regulated the expression of some IAPs in endometrial tissues. These results suggest that stage-specific IAP expression in the endometrium during the estrous cycle and pregnancy and in chorioallantoic tissues during pregnancy may play important roles in reproductive cyclicity and in the establishment and maintenance of pregnancy by regulating apoptosis and epithelial differentiation in pigs.